tiprankstipranks
Trending News
More News >
MANAC Chemical Partners Co.,Ltd (JP:4360)
:4360
Japanese Market
Advertisement

MANAC Chemical Partners Co.,Ltd (4360) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4360

MANAC Chemical Partners Co.,Ltd

(4360)

Rating:46Neutral
Price Target:
MANAC Chemical Partners Co., Ltd's overall stock score is primarily impacted by weak financial performance and bearish technical indicators. The financial challenges include declining profitability and cash flow issues, despite a strong equity base. Technical analysis shows the stock is in a downtrend, with weak momentum indicators. The valuation is high, with a significant P/E ratio, suggesting the stock may be overvalued despite a reasonable dividend yield.

MANAC Chemical Partners Co.,Ltd (4360) vs. iShares MSCI Japan ETF (EWJ)

MANAC Chemical Partners Co.,Ltd Business Overview & Revenue Model

Company DescriptionMANAC Chemical Partners Co.,Ltd, together with its subsidiaries, engages in the development, manufacture, sale, import, and export of industrial chemicals and pharmaceuticals in Japan. It is also involved in the supply of raw materials, including flame retardants, antibacterial agents, veterinary drugs, food additives, photosensitive materials, and other materials to technological industries of various fields. In addition, the company provides warehouse leasing services. MANAC Chemical Partners Co.,Ltd was founded in 1948 and is based in Tokyo, Japan.
How the Company Makes MoneyMANAC Chemical Partners Co., Ltd generates revenue through the production and sale of specialty chemicals used in various industrial applications. The company's primary revenue streams include the sale of chemical products to industries like pharmaceuticals, agriculture, and electronics, among others. Additionally, the company may engage in strategic partnerships and collaborations with other firms to enhance its product offerings and expand its market reach. Factors contributing to its earnings include its focus on innovation, efficient production processes, and maintaining strong relationships with its clients.

MANAC Chemical Partners Co.,Ltd Financial Statement Overview

Summary
MANAC Chemical Partners Co., Ltd faces significant challenges with declining profitability and cash flow issues. Despite a strong equity base, the company struggles with operational efficiency and cash flow generation. Strategic improvements in operational and cash management are vital for future stability and growth.
Income Statement
45
Neutral
The company's revenue has decreased over the years, with a significant decline in gross and net profit margins. The gross profit margin for TTM is approximately 17.32%, and the net profit margin is about 0.08%, reflecting operational challenges. EBIT and EBITDA margins have also weakened, indicating declining operational efficiency.
Balance Sheet
70
Positive
The balance sheet shows strong equity, with an equity ratio of about 79.29% for TTM, indicating financial stability. The debt-to-equity ratio is 0, suggesting no reliance on debt. However, the return on equity (ROE) is low at around 0.07% for TTM due to minimal net income, pointing to inefficient equity utilization.
Cash Flow
40
Negative
Cash flow metrics are concerning with negative free cash flow growth, as the company generated no free cash flow in the TTM period. The operating cash flow to net income ratio is unavailable, indicating potential cash flow management issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.30B9.30B9.69B11.85B10.70B
Gross Profit1.47B1.47B1.82B2.81B2.43B
EBITDA-385.50M-312.00M545.00M1.62B1.19B
Net Income-895.00M-895.00M82.00M821.00M712.00M
Balance Sheet
Total Assets12.65B12.65B14.10B15.01B13.59B
Cash, Cash Equivalents and Short-Term Investments2.77B2.77B3.29B3.72B2.04B
Total Debt0.000.000.00290.00M291.00M
Total Liabilities2.34B2.34B2.85B3.97B3.29B
Stockholders Equity10.30B10.30B11.25B11.04B10.29B
Cash Flow
Free Cash Flow0.00-411.00M-593.00M1.40B30.00M
Operating Cash Flow0.00108.00M-118.00M1.65B714.00M
Investing Cash Flow0.00-489.00M-231.00M199.00M-422.00M
Financing Cash Flow0.00-126.00M-75.00M-125.00M-200.00M

MANAC Chemical Partners Co.,Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price583.00
Price Trends
50DMA
540.82
Positive
100DMA
525.13
Positive
200DMA
550.02
Positive
Market Momentum
MACD
10.08
Positive
RSI
59.37
Neutral
STOCH
19.70
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4360, the sentiment is Positive. The current price of 583 is below the 20-day moving average (MA) of 585.80, above the 50-day MA of 540.82, and above the 200-day MA of 550.02, indicating a neutral trend. The MACD of 10.08 indicates Positive momentum. The RSI at 59.37 is Neutral, neither overbought nor oversold. The STOCH value of 19.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4360.

MANAC Chemical Partners Co.,Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥9.99B11.65
1.74%13.02%
73
Outperform
¥6.05B8.43
3.24%19.66%-13.42%
68
Neutral
¥6.87B6.67
1.87%6.80%-19.87%
68
Neutral
¥4.82B33.59
1.19%-5.30%-6.24%
65
Neutral
¥2.76B12.38
3.34%4.46%-27.46%
61
Neutral
$10.41B7.18-0.06%2.87%2.87%-36.73%
46
Neutral
¥5.03B521.41
2.57%1.73%-914.83%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4360
MANAC Chemical Partners Co.,Ltd
584.00
71.91
14.04%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
2,910.00
546.31
23.11%
JP:4366
Daito Chemix Corporation
931.00
344.10
58.63%
JP:4531
Yuki Gosei Kogyo Co., Ltd.
276.00
16.71
6.44%
JP:4885
MUROMACHI CHEMICALS INC.
748.00
9.85
1.33%
JP:4960
Chemipro Kasei Kaisya,Ltd.
295.00
-91.02
-23.58%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 22, 2025